Provided by Tiger Trade Technology Pte. Ltd.

OKYO PHARMA LTD

1.39
-0.0200-1.42%
Post-market: 1.37-0.0200-1.44%16:43 EDT
Volume:27.51K
Turnover:37.86K
Market Cap:72.95M
PE:-5.79
High:1.46
Open:1.43
Low:1.35
Close:1.41
52wk High:3.20
52wk Low:1.26
Shares:52.48M
Float Shares:28.04M
Volume Ratio:0.79
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2400
EPS(LYR):-0.2400
ROE:-263.78%
ROA:-43.09%
PB:5.91
PE(LYR):-5.79

Loading ...

OKYO Pharma Chairman Raises Stake to 20.51% After Buying 25,000 Shares at $ 1.4

Reuters
·
Jul 21

OKYO Pharma Files Annual Report and Secures Funding for Phase 3 NEPTUNE Trial

TIPRANKS
·
Jul 20

OKYO Pharma Says Cash Position Funds Completion of Neptune Phase 3 Urcosimod Trial

Reuters
·
Jul 20

OKYO Pharma FY26 Net Loss Widens to $8.95 Million

Reuters
·
Jul 20

OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans

GlobeNewswire
·
Jul 20

OKYO Pharma is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 13

Okyo Pharma receives feedback from FDA Type D meeting on urcosimod pathway

TIPRANKS
·
Jul 08

OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain

GlobeNewswire
·
Jul 08

OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium

GlobeNewswire
·
Jul 07

OKYO Pharma files Form 3 initial beneficial ownership for CMO Flavio Mantelli

Reuters
·
Jun 18

OKYO Pharma files Form 3 as director Bernard Denoyer reports beneficial ownership holdings

Reuters
·
Jun 03

OKYO Pharma files Form 3 for director John P. Brancaccio initial beneficial ownership statement

Reuters
·
Jun 02

OKYO Pharma files Form 3 for CEO, director Robert Dempsey beneficial ownership statement

Reuters
·
May 23

OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain

TIPRANKS
·
May 19

OKYO Pharma appoints Marta Sacchetti to scientific advisory board

Reuters
·
May 19

Press Release: OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD

Dow Jones
·
May 19

OKYO Pharma CEO to present at Eyecelerator conference

Reuters
·
Apr 29